Niuhuang Jiangya Preparation (a traditional Chinese patent medicine) for essential hypertension: A systematic review

Complementary Therapies in Medicine

Volumn 31, Issue , 2017, Pages 90-99

  Wang, Hui ^a   Liu, Chunxiang ^a   Zhai, Jingbo ^a   Shang, Hongcai ^b  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Essential hypertension; Meta analysis; Niuhuang Jiangya Preparation; Systematic review

Indexed keywords

HERBACEOUS AGENT; NIUHUANG JIANGYA PREPARATION; UNCLASSIFIED DRUG; NIUHUANG;

ABDOMINAL DISCOMFORT; BLOOD PRESSURE REGULATION; CHINESE MEDICINE; COUGHING; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; ESSENTIAL HYPERTENSION; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; BLOOD PRESSURE; HYPERTENSION;

BLOOD PRESSURE; DRUGS, CHINESE HERBAL; HUMANS; HYPERTENSION; MEDICINE, CHINESE TRADITIONAL; TREATMENT OUTCOME;

EID: 85014543734     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2017.02.005     Document Type: Review

References (24)

1. 1 Zi-chuan, Tong, Management of high blood pressure in China-Learning from the panel members appointed to the eighth joint national committee (JNC8) Guideline. Chin J Clin 43:5 (2015), 6–8.
2. 2 Lewing, S., Clarke, R., Qizilbash, N., et al. Age specific relevance of usual blood pressure to vascular mortality: a meta analysis of individual data for one million adults in 61 prospective studies. Lancet 360:9349 (2002), 1903–1913.
3. 3 Chinese Hypertension Prevention Guide Revision Committee, The 2010 Chinese guidelines for the management of hypertension. Chin J Hypertens 19:8 (2011), 701–743.
4. 4 Wang, et al. Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens, 3(April), 2014.
5. 5 James, P.A., Oparil, S., Carter, B.L., et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA 311:December (5) (2013), 507–520, 10.1001/jama.2013.284427 [PMID 24352797].
6. 6 Ernst, E., Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ 78:2 (2000), 252–257.
7. 7 Chen, K.J., Hui, K.K., Lee, M.S., Xu, H., The potential benefit of complementary/alternative medicine in cardiovascular diseases. Evid-Based Complement Alternat Med, 2012, 2012, 1 [Article ID 125029].
8. 8 Chinese Hypertension Prevention Guide Revision Committee, Chinese hypertension prevention guide. J Hypertens 8:1 (2000), 94–104.
9. 9 Chinese Hypertension Prevention Guide Revision Committee, Chinese hypertension prevention guide 2004. J Hypertens 12:6 (2004), 483–486.
10. 10 Chinese Hypertension Prevention Guide Revision Committee, Chinese hypertension prevention guide 2010. Chin J Hypertens 19:8 (2011), 701–743.
11. 11 WHO-ISH Hypertension Guidelines Committee, World Health Organization-International Society of hypertension guidelines for the management of hypertension. J Hypertens 17:2 (1999), 151–183.
12. 12 Higgins, J., Green, S., Cochrane Handbook for Systematic Review of Interventions Version 5. 1. 0 [updated March 2011]. 2011, The Cochrane Collaboration www.Cochrane-hand-book.org.
13. 13 Feng, Liu, Clinical efficacy of captopril on the treatment of hypertension in the elderly. Mod Med, 02, 2011, 139.
14. 14 Shou-an, Yu, Zhao-an, Yu, Clinical observations on the therapeutic effect of Niuhuang Jiangya capsule in improve men's blood pressure and erectile function. China J Chin Mater Med 09 (2006), 781–782.
15. 15 Yin-rong, Liu, Zhe-ming, Wu, Clinical observations of Niuhuang Jiangya capsule in the treatment of mild, medium hypertension. Guangxi J Tradition Chin Med 05 (2002), 13–14.
16. 16 Sui-xin, Liu, Ming, Sun, You-fu, Luo, et al. Clinical study of niuhuang jiangya capsule in the treatment of essential hypertension. Chin J Integrat Tradit West Med 06 (2004), 553–555.
17. 17 Lun, Dai, Yong-jun, Wang, Efficacy of Niuhuang Jiangya pills on hypertensive patients with anxiety. China J Chin Mater Med 20 (2006), 1743–1744.
18. 18 Yuan, Zhi-da, Observation of Niuhuang Jiangya pills combined with amlodipine in the treatment of Hypertension. J Hebei United Univ (Health Sci) 04 (2012), 514–515.
19. 19 Lan-jun, Sun, Kui, Pu, Ke-qiang, Liu, et al. randomized double-blind controlled study of Niuhuang Jiangya pills combined with felodipine in the treatment of Hypertension. Fourth World Integrative Medicine Congress, 2012.
20. 20 Bing-hui, Cai, Observation of Niuhuang Jiangya pills combined with captopril in the treatment of essential hypertension. Tianjin Pharm 2009:04 (2016), 36–37.
21. 21 Xiaofang, Ding, Random parallel control study bezoar dropping pill treatment of high blood pressure. J Pract Tradit Chin Intern Med 14 (2013), 58–60.
22. 22 Yan-xia, Wang, Bezoar dropping pill treatment of senile simple systolic hypertension disease curative effect observation. Cardiovasc Dis J Integrat Tradit Chin West Med 08 (2014), 7–9.
23. 23 Duan-qiu, Zhou, Hai-yan, Zhou, Zheng-zheng, Yang, et al. Clinical study of Niuhuang Jiangya pills in the treatment of essential hypertension. China J Chin Mater Med 07 (2006), 612–614.
24. 24 Xin-xin, Geng, Chun-feng, Qiao, Xiang, Wang, et al. Clinical analysis of treating essential hypertension with liver-yang hyperactivity in the integrative medicine. Guide China Med 26 (2011), 325–326.